Researchers develop simple method for capturing proteins implicated in Alzheimer's, other conditions
Can't see this email? View it online
   
  July 19, 2017  
  Alzheimer's Disease  
  The latest Alzheimer's disease news from News Medical  
 Researchers develop simple method for capturing proteins implicated in Alzheimer's, other conditionsResearchers develop simple method for capturing proteins implicated in Alzheimer's, other conditions
 
A simple methodology for capturing proteins implicated in the development of Alzheimer's disease and other conditions has been developed by researchers at the University of Bradford and University of Dundee.
 
 
 E-Scape Bio announces extension of funding to develop novel drug for Alzheimer's diseaseE-Scape Bio announces extension of funding to develop novel drug for Alzheimer's disease
 
E-Scape Bio announced an extension of its Series A funding to a total of $63 million. Created as a spin-off from research conducted at the Gladstone Institutes, E-Scape Bio is a biopharmaceutical company with a mission to develop new therapies to treat neurodegenerative disorders such as Alzheimer's disease.
 
   ASU-TGen researchers find source of altered ANK1 gene expression linked to Alzheimer's diseaseASU-TGen researchers find source of altered ANK1 gene expression linked to Alzheimer's disease
 
Researchers led by Arizona State University and the Translational Genomics Research Institute have identified altered expression of a gene called ANK1, which only recently has been associated with memory robbing Alzheimer's disease, in specific cells in the brain.
 
   Combining care program with drug reduces damaging effects of Alzheimer's diseaseCombining care program with drug reduces damaging effects of Alzheimer's disease
 
Combining a specific care management program with a commonly-prescribed drug for Alzheimer's disease multiplies the medication's ability to improve daily function by about 7.5 times, stalling some of the disease's most damaging effects.
 
   Researchers study molecular mechanisms responsible for Alzheimer's diseaseResearchers study molecular mechanisms responsible for Alzheimer's disease
 
Members of the Faculty of Fundamental Medicine at the Lomonosov Moscow State University have determined the structure of a peptide complex, formed in the brain at the early stages of Alzheimer's disease progression.
 
 Researchers spot two genes that influence person's risk of Alzheimer's disease
 
Researchers spot two genes that influence person's risk of Alzheimer's diseaseA team of researchers led by Cardiff University has identified two genes that influence a person's risk of developing Alzheimer's disease.
 
 
 Researchers find increased bacterial populations in Alzheimer's brains
 
Researchers find increased bacterial populations in Alzheimer's brainsResearchers in the UK have used DNA sequencing to examine bacteria in post-mortem brains from patients with Alzheimer's disease.
 
 
 Racial disparity in dementia risk, experts report
 
Racial disparity in dementia risk, experts reportA series of studies presented at the 2017 Alzheimer’s Association International Conference (AAIC 2017) has highlighted racial inequities in the risk of dementia. The studies showed that the number of people with Alzheimer’s and other dementias differed between races and also suggested that stress in early life and neighborhood disadvantage contribute to increased dementia risk.
 
 
 A heart-healthy diet may lower risk of cognitive impairment in old age, studies suggest
 
A heart-healthy diet may lower risk of cognitive impairment in old age, studies suggestA diet designed to improve cardiovascular health is associated with improved cognitive maintenance in old age, say researchers. The finding comes from four large-scale, population-based studies that were reported on at the 2017 Alzheimer’s Association International Conference (AAIC) in London.
 
 
 Dementia researchers to receive £1.9 million funding for brain imaging project
 
Dementia researchers to receive £1.9 million funding for brain imaging projectDementia researchers are to receive a £1.9 million investment to identify the earliest brain changes associated with conditions such as Alzheimer's disease.
 
 
 Inhibition of cell receptors clears toxic proteins, cuts inflammation and improves cognition in animal models
 
Inhibition of cell receptors clears toxic proteins, cuts inflammation and improves cognition in animal modelsResearchers have found cell receptors abnormally overexpressed in post-mortem brains of those with Parkinson's and Alzheimer's diseases, and that they can be inhibited in animal models to clear toxic protein buildup, reduce brain inflammation, and improve cognitive performance.